Airimedus - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 162,768 | 265,515 | 249,747 | 229,764 | 264,132 | 205,924 | 217,387 | 232,923 |
| Profit before tax | 6,292 | 5,953 | 3,546 | 7,364 | 6,120 | 2,787 | 4,143 | 10,287 |
| Net profit | 5,915 | 5,582 | 3,327 | 6,974 | 5,796 | 2,573 | 3,713 | 9,595 |
| Equity | 125,757 | 117,210 | 110,521 | 96,296 | 87,704 | 86,495 | 65,914 | 64,309 |
| Liabilities | 129,441 | 89,597 | 74,554 | 95,469 | 97,906 | 84,651 | 70,702 | 75,292 |
| Non-current assets | 4,236 | 21,651 | 15,459 | 76,286 | 106,990 | 86,902 | 87,281 | 87,918 |
| Current assets | 250,467 | 184,165 | 168,928 | 115,057 | 78,127 | 83,692 | 48,774 | 51,077 |
| Total assets | 254,703 | 205,816 | 184,387 | 191,343 | 185,117 | 170,594 | 136,055 | 138,995 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 33,649 | 20,596 | 32,418 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -11.6% | +63.1% | -5.9% | -8.0% | +15.0% | -22.0% | +5.6% | +7.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 2.3% | 2.7% | 1.8% | 3.6% | 3.1% | 1.5% | 2.7% | 6.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 4.7% | 4.8% | 3.0% | 7.2% | 6.6% | 3.0% | 5.6% | 14.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 3.6% | 2.1% | 1.3% | 3.0% | 2.2% | 1.2% | 1.7% | 4.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 3.9% | 2.2% | 1.4% | 3.2% | 2.3% | 1.4% | 1.9% | 4.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.0 | 0.8 | 0.7 | 1.0 | 1.1 | 1.0 | 1.1 | 1.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 162,768 | 265,515 | 249,747 | 125,328 | 132,066 | 107,437 | 217,387 | 232,923 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Airimedus - Social security debts
The company had no debts to Sodra
Airimedus - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Airimedus, UAB (code 126237331) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €232.9K, which was 7.2% higher than in 2024 and 13.1% higher over two years. Net profit rose to €9.6K in 2025 from €3.7K in 2024 and €2.6K in 2023, while the profit margin improved to 4.1% from 1.7% and 1.2% in the previous two years. The balance sheet remained modest: total assets stood at €139.0K in 2025, slightly above €136.1K in 2024 but below €170.6K in 2023. Equity was €64.3K and liabilities €75.3K, compared with €65.9K and €70.7K in 2024. Long-term assets were €87.9K and short-term assets €51.1K. For 2025, key ratios indicate ROE of 14.9%, ROA of 6.9%, debt-to-equity of 1.17, and asset turnover of 1.68x. Revenue per employee was €232.9K, showing solid productivity.